Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001243401 | SCV001416558 | uncertain significance | Fanconi anemia | 2021-04-11 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with FANCM-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with threonine at codon 1910 of the FANCM protein (p.Arg1910Thr). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and threonine. |
Ambry Genetics | RCV004619582 | SCV005113472 | uncertain significance | Inborn genetic diseases | 2024-04-09 | criteria provided, single submitter | clinical testing | The c.5729G>C (p.R1910T) alteration is located in exon 22 (coding exon 22) of the FANCM gene. This alteration results from a G to C substitution at nucleotide position 5729, causing the arginine (R) at amino acid position 1910 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |